Literature DB >> 15350958

Participation bias in a population-based echocardiography study.

Steven J Jacobsen1, Douglas W Mahoney, Margaret M Redfield, Kent R Bailey, John C Burnett, Richard J Rodeheffer.   

Abstract

PURPOSE: To compare the characteristics of participants and non-participants in a population-based study of cardiac ventricular function.
METHODS: Subjects aged 45 years and older on January 1, 1997 were recruited from a sampling frame of Olmsted County residents from the Rochester Epidemiology Project. Subjects were asked to complete a 17-page questionnaire and participate in a 4-hour clinical examination that included a brief physical examination, echocardiography, spirometry, and an electrocardiogram. With specific IRB approval, the community medical records of participants and non-participants from the first wave of recruitment were examined by trained nurse abstractors to elicit details of past medical history.
RESULTS: Of the first 963 persons invited to participate in the study, 488 (51%) completed all phases of the examination. Participation rates were similar among men and women (53% vs. 49%, respectively). By age, participation rates were lowest among persons aged 75 years and older (44.7% and 34.9%) and 45 to 54 years (45.4% and 44.3%) for men and women. Participation rates were not different according to past history of coronary heart disease, congestive heart failure, or other cardiovascular disease. Persons with a history of chronic obstructive pulmonary disease were less likely to participate (19.4% vs. 51%; odds ratio, 0.36; 95% confidence interval, 0.18, 0.76) after adjustment for age, sex, and comorbid conditions.
CONCLUSIONS: These results provide some reassurance that participation bias in this study may have little influence on its overall findings, although this cannot be conclusive.

Entities:  

Mesh:

Year:  2004        PMID: 15350958     DOI: 10.1016/j.annepidem.2003.11.001

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  32 in total

1.  Association between Adiposity and disability in the Lc65+ Cohort.

Authors:  N Danon-Hersch; S Fustinoni; P Bovet; J Spagnoli; B Santos-Eggimann
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

2.  Impaired functional status and echocardiographic abnormalities signifying global dysfunction enhance the prognostic significance of previously unrecognized myocardial infarction detected by electrocardiography.

Authors:  Khawaja Afzal Ammar; Ravindrakumar Makwana; Steven J Jacobsen; Jan A Kors; John C Burnett; Margaret M Redfield; Barbara P Yawn; Richard J Rodeheffer
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-01       Impact factor: 1.468

3.  Hip fracture prevention with a multifactorial educational program in elderly community-dwelling Finnish women.

Authors:  T Pekkarinen; E Löyttyniemi; M Välimäki
Journal:  Osteoporos Int       Date:  2013-05-08       Impact factor: 4.507

4.  Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease.

Authors:  Cynthia S Crowson; Elena Myasoedova; John M Davis; Veronique L Roger; Barry L Karon; Daniel Borgeson; Richard J Rodeheffer; Terry M Therneau; Sherine E Gabriel
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-05       Impact factor: 4.794

5.  The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects.

Authors:  Paul M McKie; Alessandro Cataliotti; Brian D Lahr; Fernando L Martin; Margaret M Redfield; Kent R Bailey; Richard J Rodeheffer; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2010-05-11       Impact factor: 24.094

6.  Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP.

Authors:  Fima Macheret; Denise Heublein; Lisa C Costello-Boerrigter; Guido Boerrigter; Paul McKie; Diego Bellavia; Sarah Mangiafico; Yasuhiro Ikeda; Kent Bailey; Christopher G Scott; Sharon Sandberg; Horng H Chen; Lorenzo Malatino; Margaret M Redfield; Richard Rodeheffer; John Burnett; Alessandro Cataliotti
Journal:  J Am Coll Cardiol       Date:  2012-10-16       Impact factor: 24.094

7.  Progression of left ventricular diastolic dysfunction and risk of heart failure.

Authors:  Garvan C Kane; Barry L Karon; Douglas W Mahoney; Margaret M Redfield; Veronique L Roger; John C Burnett; Steven J Jacobsen; Richard J Rodeheffer
Journal:  JAMA       Date:  2011-08-24       Impact factor: 56.272

8.  Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure.

Authors:  Paul M McKie; Richard J Rodeheffer; Alessandro Cataliotti; Fernando L Martin; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Margaret M Redfield; John C Burnett
Journal:  Hypertension       Date:  2006-04-03       Impact factor: 10.190

9.  Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg.

Authors:  Ala'a Alkerwi; Nicolas Sauvageot; Sophie Couffignal; Adelin Albert; Marie-Lise Lair; Michèle Guillaume
Journal:  BMC Med Res Methodol       Date:  2010-09-07       Impact factor: 4.615

10.  Abnormal cardiac structure and function in the metabolic syndrome: a population-based study.

Authors:  Bilal Aijaz; Khawaja A Ammar; Francisco Lopez-Jimenez; Margaret M Redfield; Steven J Jacobsen; Richard J Rodeheffer
Journal:  Mayo Clin Proc       Date:  2008-12       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.